IRDAI Penalises Edelweiss Life, Pramerica Life Over Expense Violations, Imposes Branch Bans
IRDAI has penalized Edelweiss Life and Pramerica Life for breaching statutory Expense of Management limits in FY 2024-25.
IRDAI freezes new branch expansions for Edelweiss Life and Pramerica Life following strict enforcement over expense limit violations.
New Delhi – IRDAI: Following its regulatory crackdown on Niva Bupa Health Insurance and Acko General Insurance yesterday, the Insurance Regulatory and Development Authority of India (IRDAI) has extended its enforcement drive to the life insurance sector. In regulatory orders issued on August 20, 2026, the insurance watchdog issued formal warnings and imposed a six-month ban on opening any new places of business against Edelweiss Life Insurance Company Limited and Pramerica Life Insurance Limited for failing to adhere to statutory Expenses of Management (EoM) limits during FY 2024-25.
Also Read: Acko’s Second EoM Breach in a Row: IRDAI Warns Insurer, Halts Expansion for Six Months
IRDAI: Regulatory Action on Edelweiss Life Insurance
Edelweiss Life Insurance breached allowable spending limits across both its non-participating and participating policy segments under Regulation 20 of the IRDAI (Expenses of Management, including Commission, of Insurers) Regulations, 2024. Against an allowable cap of ₹494.09 crore for its non-participating segment, the insurer incurred ₹558.73 crore (an excess of ₹64.64 crore), while its participating segment incurred ₹264.81 crore against an allowable limit of ₹239.50 crore (an excess of ₹25.31 crore).
This resulted in an aggregate overspend of ₹89.95 crore. During a personal hearing held at IRDAI’s Hyderabad office on January 29, 2026, Edelweiss argued that its overall EoM ratio had improved progressively from 135% in FY 2021-22 to 112% in FY 2024-25, supported by forbearance recommendations from the Life Insurance Council. However, IRDAI rejected the request, emphasizing that the insurer was a repeat non-compliant entity having also exceeded allowable limits in FY 2023-24.
IRDAI: Pramerica Life Penalized for Non-Participating Overspend
Pramerica Life Insurance faced similar regulatory penalties for failing to keep its operational expenses within permissible limits under Regulation 20(2). The insurer posted total actual expenses of ₹747.73 crore in its non-participating segment against an allowable ceiling of ₹609.94 crore, accumulating an overspend of ₹137.79 crore for FY 2024-25. Despite Pramerica highlighting ongoing governance corrections and a demonstrable improvement in its expense trajectory during its personal hearing on January 29, 2026, the regulator turned down its plea for leniency. Citing the company’s previous non-compliance in FY 2023-24, IRDAI invoked Regulation 22(1)(b) and (c) to bar Pramerica from expanding its physical branch footprint or opening new offices for six months.
Also Read: IRDAI Warns Niva Bupa Health Insurance Over Expenses Breach, Bars New Branches for 6 Months
IRDAI: Governance Mandates and Sector-Wide Impact
Both life insurers have been directed to present the IRDAI orders before their respective Boards of Directors during upcoming board meetings and submit certified copies of the discussion minutes to the regulator within 15 days. Under Section 110 of the Insurance Act, 1938, both companies retain the right to appeal the orders before the Securities Appellate Tribunal (SAT).
These decisions closely follow yesterday’s stern enforcement against major non-life players. Acko General Insurance was penalized after incurring ₹985.15 crore in actual expenses against an allowable cap of ₹650.37 crore, resulting in an excess spend of ₹334.78 crore. Similarly, Niva Bupa Health Insurance breached its allowable limit of ₹2,403.75 crore by spending ₹2,652.12 crore, marking an overspend of ₹248.37 crore. Both non-life entities received identical six-month branch expansion halts, underscoring IRDAI’s firm commitment to curbing administrative overspending and safeguarding policyholder capital across the sector.
With a mandatory six-month freeze on physical network growth now in place across all four companies, affected insurers will be forced to pivot aggressively toward operational rationalization, digital acquisition, and distribution channel cost controls to stay within compliance.
IRDAI’s unyielding stance sends a definitive message to the broader Indian insurance market that top-line growth and market share expansion cannot come at the expense of financial discipline, ultimately ensuring that policyholder capital is safeguarded from unsustainable overhead costs.
